Skyrocketing demand for weight loss and diabetes drugs has forced Eli Lilly and Novo Nordisk, to invest billions to increase manufacturing capacity.
Related Posts
Judge to consider extending pause on Trump’s federal worker buyout plan
The buyout plan has been promoted by Elon Musk, the head of President Donald Trump’s so-called Department of Government Efficiency.
Watch live: Trump signs resolutions to roll back California’s EV plans
The three resolutions are part of Trump’s broader repeal of Biden-era rules to promote electric vehicle and green energy adoption.
Microsoft loses status as OpenAI’s exclusive cloud provider
Microsoft won’t be the sole cloud provider for OpenAI but can decide whether to deliver the company with capacity or allow another party to fill […]